SCHEMBL19904566

SCHEMBL19904566

C=COc1ccc(CC(CN2CCCC2)NC(=O)[C@@H]2CCN(c3ccc(Cl)cc3)C2)cc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 4/20 0.39
CCR1 P32246 1/20 0.39
HTR1A P08908 1/20 0.38
FFAR1 O14842 1/20 0.37
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.34
WDR91 A4D1P6 1/20 0.34
OPRM1 P35372 1/20 0.34
OPRD1 P41143 1/20 0.34
UGCG Q16739 1/20 0.34
ACHE P22303 1/20 0.34
GAA P10253 1/20 0.34
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19904651 0.89 CCR1 (0.43) NOTUMCCR1HTR1AMEN1ALDH1A1
SCHEMBL19904415 0.89 CCR1 (0.43) NOTUMCCR1HTR1AMEN1ALDH1A1
SCHEMBL19904316 0.89 UGCG (0.43) NOTUMCCR1HTR1AFFAR1UGCG
SCHEMBL19904428 0.89 UGCG (0.43) NOTUMCCR1HTR1AFFAR1UGCG
SCHEMBL19904540 0.88 CCR1 (0.41) NOTUMCCR1HTR1AFFAR1MEN1
SCHEMBL19904478 0.88 UGCG (0.43) NOTUMCCR1HTR1AFFAR1UGCG
SCHEMBL19904504 0.88 UGCG (0.41) NOTUMCCR1HTR1AFFAR1UGCG
SCHEMBL19904697 0.88 UGCG (0.41) NOTUMCCR1HTR1AFFAR1UGCG
SCHEMBL19904680 0.87 UGCG (0.42) NOTUMCCR1HTR1AFFAR1UGCG
SCHEMBL19904655 0.86 UGCG (0.42) NOTUMCCR1HTR1AFFAR1UGCG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3063141-B1 N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS BIOMARIN PHARM INC (US) 2018-02-28 EP disclosed